Literature DB >> 26550463

The human subject: an integrative animal model for 21(st) century heart failure research.

P Charukeshi Chandrasekera1, John J Pippin1.   

Abstract

Heart failure remains a leading cause of death and it is a major cause of morbidity and mortality affecting tens of millions of people worldwide. Despite decades of extensive research conducted at enormous expense, only a handful of interventions have significantly impacted survival in heart failure. Even the most widely prescribed treatments act primarily to slow disease progression, do not provide sustained survival advantage, and have adverse side effects. Since mortality remains about 50% within five years of diagnosis, the need to increase our understanding of heart failure disease mechanisms and development of preventive and reparative therapies remains critical. Currently, the vast majority of basic science heart failure research is conducted using animal models ranging from fruit flies to primates; however, insights gleaned from decades of animal-based research efforts have not been proportional to research success in terms of deciphering human heart failure and developing effective therapeutics for human patients. Here we discuss the reasons for this translational discrepancy which can be equally attributed to the use of erroneous animal models and the lack of widespread use of human-based research methodologies and address why and how we must position our own species at center stage as the quintessential animal model for 21(st) century heart failure research. If the ultimate goal of the scientific community is to tackle the epidemic status of heart failure, the best way to achieve that goal is through prioritizing human-based, human-relevant research.

Entities:  

Keywords:  Heart failure; animal models; human relevance; human-based research; translatability

Year:  2015        PMID: 26550463      PMCID: PMC4626425     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  58 in total

1.  The impossible task of developing a new treatment for heart failure.

Authors:  Milton Packer
Journal:  J Card Fail       Date:  2002-08       Impact factor: 5.712

2.  Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure.

Authors:  B M Mayosi; A Kardos; C H Davies; F Gumedze; A Hovnanian; S Burge; H Watkins
Journal:  Heart       Date:  2005-04-21       Impact factor: 5.994

Review 3.  Animal models of heart failure: a scientific statement from the American Heart Association.

Authors:  Steven R Houser; Kenneth B Margulies; Anne M Murphy; Francis G Spinale; Gary S Francis; Sumanth D Prabhu; Howard A Rockman; David A Kass; Jeffery D Molkentin; Mark A Sussman; Walter J Koch; Walter Koch
Journal:  Circ Res       Date:  2012-05-17       Impact factor: 17.367

4.  Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusion.

Authors:  Robert A Kaiser; Jefferson M Lyons; Jodie Y Duffy; Connie J Wagner; Kelly M McLean; Timothy P O'Neill; Jeffrey M Pearl; Jeffery D Molkentin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-02       Impact factor: 4.733

Review 5.  Cardiomyopathy: an overview.

Authors:  Randell K Wexler; Terry Elton; Adam Pleister; David Feldman
Journal:  Am Fam Physician       Date:  2009-05-01       Impact factor: 3.292

Review 6.  Distinguishing between mouse and human pluripotent stem cell regulation: the best laid plans of mice and men.

Authors:  Angelique Schnerch; Chantal Cerdan; Mickie Bhatia
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

7.  Blood signature of pre-heart failure: a microarrays study.

Authors:  Fatima Smih; Franck Desmoulin; Matthieu Berry; Annie Turkieh; Romain Harmancey; Jason Iacovoni; Charlotte Trouillet; Clement Delmas; Atul Pathak; Olivier Lairez; François Koukoui; Pierre Massabuau; Jean Ferrieres; Michel Galinier; Philippe Rouet
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

8.  Heart disease is common in humans and chimpanzees, but is caused by different pathological processes.

Authors:  Nissi Varki; Dan Anderson; James G Herndon; Tho Pham; Christopher J Gregg; Monica Cheriyan; James Murphy; Elizabeth Strobert; Jo Fritz; James G Else; Ajit Varki
Journal:  Evol Appl       Date:  2009-02       Impact factor: 5.183

Review 9.  Efficacy of female rat models in translational cardiovascular aging research.

Authors:  K M Rice; J C Fannin; C Gillette; E R Blough
Journal:  J Aging Res       Date:  2014-12-31

10.  Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes.

Authors:  Yao-Peng Hsieh; Ching-Hui Huang; Chia-Ying Lee; Ching-Yuang Lin; Chia-Chu Chang
Journal:  J Occup Med Toxicol       Date:  2014-03-18       Impact factor: 2.646

View more
  7 in total

Review 1.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

2.  The genomics of heart failure: design and rationale of the HERMES consortium.

Authors:  R Thomas Lumbers; Sonia Shah; Honghuang Lin; Tomasz Czuba; Albert Henry; Daniel I Swerdlow; Anders Mälarstig; Charlotte Andersson; Niek Verweij; Michael V Holmes; Johan Ärnlöv; Per Svensson; Harry Hemingway; Neneh Sallah; Peter Almgren; Krishna G Aragam; Geraldine Asselin; Joshua D Backman; Mary L Biggs; Heather L Bloom; Eric Boersma; Jeffrey Brandimarto; Michael R Brown; Hans-Peter Brunner-La Rocca; David J Carey; Mark D Chaffin; Daniel I Chasman; Olympe Chazara; Xing Chen; Xu Chen; Jonathan H Chung; William Chutkow; John G F Cleland; James P Cook; Simon de Denus; Abbas Dehghan; Graciela E Delgado; Spiros Denaxas; Alexander S Doney; Marcus Dörr; Samuel C Dudley; Gunnar Engström; Tõnu Esko; Ghazaleh Fatemifar; Stephan B Felix; Chris Finan; Ian Ford; Francoise Fougerousse; René Fouodjio; Mohsen Ghanbari; Sahar Ghasemi; Vilmantas Giedraitis; Franco Giulianini; John S Gottdiener; Stefan Gross; Daníel F Guðbjartsson; Hongsheng Gui; Rebecca Gutmann; Christopher M Haggerty; Pim van der Harst; Åsa K Hedman; Anna Helgadottir; Hans Hillege; Craig L Hyde; Jaison Jacob; J Wouter Jukema; Frederick Kamanu; Isabella Kardys; Maryam Kavousi; Kay-Tee Khaw; Marcus E Kleber; Lars Køber; Andrea Koekemoer; Bill Kraus; Karoline Kuchenbaecker; Claudia Langenberg; Lars Lind; Cecilia M Lindgren; Barry London; Luca A Lotta; Ruth C Lovering; Jian'an Luan; Patrik Magnusson; Anubha Mahajan; Douglas Mann; Kenneth B Margulies; Nicholas A Marston; Winfried März; John J V McMurray; Olle Melander; Giorgio Melloni; Ify R Mordi; Michael P Morley; Andrew D Morris; Andrew P Morris; Alanna C Morrison; Michael W Nagle; Christopher P Nelson; Christopher Newton-Cheh; Alexander Niessner; Teemu Niiranen; Christoph Nowak; Michelle L O'Donoghue; Anjali T Owens; Colin N A Palmer; Guillaume Paré; Markus Perola; Louis-Philippe Lemieux Perreault; Eliana Portilla-Fernandez; Bruce M Psaty; Kenneth M Rice; Paul M Ridker; Simon P R Romaine; Carolina Roselli; Jerome I Rotter; Christian T Ruff; Marc S Sabatine; Perttu Salo; Veikko Salomaa; Jessica van Setten; Alaa A Shalaby; Diane T Smelser; Nicholas L Smith; Kari Stefansson; Steen Stender; David J Stott; Garðar Sveinbjörnsson; Mari-Liis Tammesoo; Jean-Claude Tardif; Kent D Taylor; Maris Teder-Laving; Alexander Teumer; Guðmundur Thorgeirsson; Unnur Thorsteinsdottir; Christian Torp-Pedersen; Stella Trompet; Danny Tuckwell; Benoit Tyl; Andre G Uitterlinden; Felix Vaura; Abirami Veluchamy; Peter M Visscher; Uwe Völker; Adriaan A Voors; Xiaosong Wang; Nicholas J Wareham; Peter E Weeke; Raul Weiss; Harvey D White; Kerri L Wiggins; Heming Xing; Jian Yang; Yifan Yang; Laura M Yerges-Armstrong; Bing Yu; Faiez Zannad; Faye Zhao; Jemma B Wilk; Hilma Holm; Naveed Sattar; Steven A Lubitz; David E Lanfear; Svati Shah; Michael E Dunn; Quinn S Wells; Folkert W Asselbergs; Aroon D Hingorani; Marie-Pierre Dubé; Nilesh J Samani; Chim C Lang; Thomas P Cappola; Patrick T Ellinor; Ramachandran S Vasan; J Gustav Smith
Journal:  ESC Heart Fail       Date:  2021-09-03

Review 3.  Links between Nutrition, Infectious Diseases, and Microbiota: Emerging Technologies and Opportunities for Human-Focused Research.

Authors:  Manuela Cassotta; Tamara Yuliett Forbes-Hernández; Ruben Calderón Iglesias; Roberto Ruiz; Maria Elexpuru Zabaleta; Francesca Giampieri; Maurizio Battino
Journal:  Nutrients       Date:  2020-06-19       Impact factor: 5.717

4.  A tissue-engineered scale model of the heart ventricle.

Authors:  Luke A MacQueen; Sean P Sheehy; Christophe O Chantre; John F Zimmerman; Francesco S Pasqualini; Xujie Liu; Josue A Goss; Patrick H Campbell; Grant M Gonzalez; Sung-Jin Park; Andrew K Capulli; John P Ferrier; T Fettah Kosar; L Mahadevan; William T Pu; Kevin Kit Parker
Journal:  Nat Biomed Eng       Date:  2018-07-23       Impact factor: 25.671

Review 5.  Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs.

Authors:  Tori Salem; Zachary Frankman; Jared M Churko
Journal:  Tissue Eng Part B Rev       Date:  2021-11-23       Impact factor: 7.376

6.  Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Authors:  Mario Cazzola; Luigino Calzetta; Ermanno Puxeddu; Josuel Ora; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2016-06-13

Review 7.  Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.

Authors:  Karina O Brandão; Viola A Tabel; Douwe E Atsma; Christine L Mummery; Richard P Davis
Journal:  Dis Model Mech       Date:  2017-09-01       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.